Aducanumab for Alzheimer disease: the amyloid hypothesis moves from bench to bedside.

J Clin Invest

Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, USA.

Published: October 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516468PMC
http://dx.doi.org/10.1172/JCI154889DOI Listing

Publication Analysis

Top Keywords

aducanumab alzheimer
4
alzheimer disease
4
disease amyloid
4
amyloid hypothesis
4
hypothesis moves
4
moves bench
4
bench bedside
4
aducanumab
1
disease
1
amyloid
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!